CLOV Clover Health Investments, Corp.
CLOV Clover Health Investments, Corp.
Healthcare · Healthcare Plans
Market read
Scan convergence 1 scan as of 2026-08-17 1 neutral converging
POC $2.67 · VWAP $3.10 · +38.0% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
CLOV Price Structure
Loading timeframes…
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-03-31: revenue $749M, diluted EPS $0.05, net income $27M (SEC filing). Across the print the stock moved +8.0% (close before → first close after).
full note →Against street estimates
How CLOV's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about CLOV from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 42 days ago · Jul 7
- Clover Health Investments (CLOV) Earnings Date and Reports 2026
- Clover Health Reports First Quarter 2026 Results
- Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect
- CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
- Clover Health (CLOV) Reports Earnings Tomorrow: What To Expect
CLOV research tape
19 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.